Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
124 hedge funds and large institutions have $519M invested in Amedisys in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 11 closing their positions.
215% more call options, than puts
Call options by funds: $5.5M | Put options by funds: $1.75M
36% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 11
17% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 41
15% more capital invested
Capital invested by funds: $452M → $519M (+$67.7M)
3% more funds holding
Funds holding: 120 → 124 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$11.3M |
| 2 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$6.38M |
| 3 |
JP Morgan Chase
New York
|
+$4.89M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$4.48M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$11.7M |
| 2 |
DM
Deerfield Management
New York
|
-$5.07M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$4.11M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.49M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.56M |
AMED Hedge Fund Activity: Q2 2014 in Review
124 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2014, worth a combined $519M — up 15% from $452M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMED positions and 11 closed out — a net gain of 4 holders — while 48 added to existing stakes and 41 trimmed.
The largest buyer was North Tide Capital, adding an estimated $11.3M. The largest seller was Wells Fargo, cutting an estimated $11.7M.
- 124 institutional investors held Amedisys (AMED) as of Q2 2014, up from 120 in Q1 2014.
- Funds reported $519M of Amedisys stock for Q2 2014, up 15% quarter-over-quarter.
- 15 funds opened new Amedisys positions in Q2 2014 and 11 closed out, a net change of +4 holders.
- The largest Amedisys buyer in Q2 2014 was North Tide Capital, an estimated $11.3M added.
- The largest Amedisys seller in Q2 2014 was Wells Fargo, an estimated $11.7M sold.
Based on aggregated 13F filings for Q2 2014.